Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How long is keytruda's patent protection?Can lipitor dose be altered with fish oil use?What are the monitoring requirements for spravato sessions?How similar is wine's impact on cholesterol to lipitor's action?How does lipitor compare to zocor in side effects?
See the DrugPatentWatch profile for nuplazid
Nuplazid (pimavanserin) is not a treatment for Parkinson’s disease symptoms such as tremor, stiffness, or bradykinesia. Nuplazid is approved for hallucinations and delusions related to Parkinson’s disease psychosis. [1]
Parkinson’s disease psychosis refers to hallucinations (seeing or hearing things) and delusions that can occur in people with Parkinson’s disease. Nuplazid is used to reduce those hallucinations and delusions, rather than to treat the motor symptoms of Parkinson’s disease. [1]
Nuplazid is also used for hallucinations and delusions associated with dementia-related psychosis in people with Parkinson’s disease and in some other dementia settings. The key point for your question is that its approved role tied to Parkinson’s is specifically for Parkinson’s disease psychosis (hallucinations and delusions), not for Parkinson’s disease itself. [1]
1
Other Questions About Nuplazid :